Trial Profile
Study of tolerance of the intravenous CIGB-128-A application in recurrent and/or progressive diffuse brain tumors
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs Interferon-alpha-2b/interferon-gamma (Primary)
- Indications Brain cancer
- Focus Adverse reactions
- Acronyms BRATINC
- 15 Feb 2013 New trial record